Abstract:Background: Non-coding RNAs (ncRNAs), like long ncRNAs (lncRNAs) and microRNAs (miRNAs), are confirmed to play important roles in the tumorigenesis and deterioration of non-small cell lung cancer (NSCLC). However, the underlying expression profiling and prospective signal pathways of miRNAs associated with lncRNA HOXA11 antisense RNA (HOXA11-AS) in NSCLC remain unknown. Methods: HOXA11-AS was knocked down in A549 cell line and a microarray assay was used to detect the changes of the miRNA profiles. Four miRNA target prediction algorithms were applied to predict the potential target genes of the differentially expressed miRNAs. Bioinformatics analysis including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interactions (PPIs) and network analysis, were performed to investigate the potential functions, pathways and networks of the target genes. The different expression of HOXA11-AS between normal lung and NSCLC tissues was further verified by the data in The Cancer Genome Atlas (TCGA). Additionally, the relationship between the expression of HOXA11-AS and clinical diagnostic value was analyzed by receiver operating characteristic (ROC) curve. Results: Among all the miRNAs from the microarray, 43 and 18 miRNAs were upregulated and downregulated in NSCLC, respectively. According to the degree of the fold change, p value and false discovery rate (FDR), the top five upregulated and downregulated miRNAs were selected for further investigation. GO analysis on the target genes revealed that these de-regulated miRNAs were involved in complex cellular pathways, such as transcription, cell junction and transcription factor activity. KEGG pathway analysis showed that Wnt signaling pathway might be involved in regulating these 10 candidate miRNAs. XRN1 (degree = 23) and EP300 (degree = 20) had highest degree and interactions in the PPI network. Additionally, we found that HOXA11-AS was upregulated in lung adenocarcinoma and squamous cell carcinoma tissues based on TCGA database. The ROC curve revealed that the area under curve (AUC) of HOXA11-AS was 0.727 (95% CI 0.663~0.790) for lung adenocarcinoma and 0.933 (95% CI 0.906~0.960) for squamous cell carcinoma patients. Conclusions: Our results provide significant information on miRNAs related to HOXA11-AS in NSCLC and we hypothesize that HOXA11-AS might play a key role in NSCLC by regulating the expression of miRNAs through Wnt signaling pathway, which would be valuable for further investigation into the possible molecular mechanisms in NSCLC.

LncRNA HOXA-AS2 Regulates Microrna-216A-5p to Promote Malignant Progression of Non-Small Cell Lung Cancer.

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

Overexpression of Lncrna HOXA11-AS Promotes Cell Epithelial–mesenchymal Transition by Repressing Mir-200B in Non-Small Cell Lung Cancer

Knockdown of Lncrna HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells

Tumour-regulatory role of long non-coding RNA HOXA-AS3

Prospective target gene network of key miRNAs influenced by long non-coding RNA HOXA 11-AS in NSCLC cells

Long Non-Coding Rna Hoxa-As2 Promotes Proliferation and Invasion of Breast Cancer by Acting As A Mir-520c-3p Sponge

LINC01207 Promotes the Progression of Non-Small Cell Lung Cancer Via Regulating ARHGAP11A by Sponging Mir-525-5p

Promising Long Noncoding RNA DLX6-AS1 in Malignant Tumors

MicroRNA-196a Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Targeting HOXA5

HOX Antisense Lincrna HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.

Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877–5p/CCNA2 pathway

Upregulation of HOXA1 Promotes Tumorigenesis and Development of Non‑small Cell Lung Cancer: A Comprehensive Investigation Based on Reverse Transcription-Quantitative Polymerase Chain Reaction and Bioinformatics Analysis.

A Novel Lncrna HOXC-AS3 Acts As a Mir-3922-5p Sponge to Promote Breast Cancer Metastasis

LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1

Long Non-Coding RNA HOXD-AS1 Promotes Tumor Progression and Predicts Poor Prognosis in Colorectal Cancer

LncRNA HOXA‐AS2 promotes the progression of epithelial ovarian cancer via the regulation of miR‐372

LncRNA HOXA‐AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‐analysis

The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma

Long non-coding RNA HOXA-AS2 may serve as a new therapeutic target and promising prognostic market for most of cancers

Overexpression of long noncoding RNA HOXA‐AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia